Private equity appetite in Indian healthcare set for spike?
This article was originally published in Scrip
Executive Summary
Private equity (PE) appetite in the Indian pharmaceutical sector is expected to emerge strongly in 2011, even after the segment witnessed the high profile exit of Actis and Sequoia Capital India from Paras Pharmaceuticals late last year.